Kiniksa Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference
Kiniksa Pharmaceuticals (Nasdaq: KNSA) will present at the 44th Annual J.P.
Rhea-AI Summary
Kiniksa Pharmaceuticals (Nasdaq: KNSA) will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 2:15 p.m. PT (5:15 p.m. ET). A live webcast will be available via the company's Investors website and a replay will be posted approximately 48 hours after the event.
Investors can access the webcast at www.kiniksa.com.
Positive
- None.
Negative
- None.
Details
News Market Reaction – KNSA
In the Jan 8 session, KNSA declined 1.63%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Conference edition
- 44th Annual
- J.P. Morgan Healthcare Conference
- Presentation date
- January 12, 2026
- Scheduled conference presentation
- Presentation time PT
- 2:15 p.m. Pacific Time
- J.P. Morgan conference slot
- Presentation time ET
- 5:15 p.m. Eastern Time
- J.P. Morgan conference slot
- Replay timing
- Within 48 hours
- Replay availability after event
Historical Context
-
Announcement of Jefferies Global Healthcare Conference presentation and webcast access.
-
Strong Q3 2025 ARCALYST revenue growth, raised guidance, and positive profitability.
-
Scheduling of Q3 2025 results call and webcast logistics for investors.
-
FDA Orphan Drug Designation granted to KPL-387 for pericarditis treatment.
-
Planned participation in Citi and Wells Fargo healthcare investor conferences.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LONDON, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 2:15 p.m. Pacific Time (5:15 p.m. Eastern Time).
A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.
Every Second Counts! ®
Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.